ArticleJournal of medical case reports2025
Cranial neuropathy during severe acute respiratory syndrome coronavirus 2 infection: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter to the Editor regarding "Cranial neuropathy during severe acute respiratory syndrome coronavirus 2 infection: a case report".Journal of medical case reports · 2026Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCranial neuropathy has been reported in association with coronavirus disease 2019. Multiple reports have highlighted the possibility of Miller Fisher syndrome as a delayed immune-mediated response to severe acute respiratory syndrome coronavirus 2 infection. However, cranial neuropathy during the infectious phase of coronavirus disease 2019 with positive cerebrospinal fluid polymerase chain reaction has not been reported to date. CASE PRESENTATION: We report a 53-year-old Iranian woman who presented with right ptosis, diplopia, and headache without any respiratory symptoms of coronavirus disease 2019. Further evaluations revealed severe acute respiratory syndrome coronavirus(SARS CoV) 2 in the patient's nasopharyngeal sample and cerebrospinal fluid. The patient's neurological symptoms improved after treatment with remdesivir and corticosteroids.
conclusionWe suggest that cranial nerve-related symptoms can occur in the context of acute severe acute respiratory syndrome coronavirus 2 infection via direct viral invasion and secondary immune-mediated injury following primary infection. Clinicians should consider coronavirus disease 2019 in patients with symptoms related to cranial nerve involvement, even without systemic or respiratory symptoms of this viral infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.